Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D Di Giuseppe
FRI0213 Comparative Effectiveness of Abatacept, Rituximab, Tocilizumab and Anti-TNF Biological Dmards in Ra: Results From the Nationwide Swedish Register
Related publications
Cost-Effectiveness of Abatacept, Tocilizumab and TNF-inhibitors Compared With Rituximab as Second-Line Biologic Drug in Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
Tocilizumab: Is There Life Beyond Anti-TNF Blockade?
International Journal of Clinical Practice
Medicine
AB0396 Tocilizumab i.v. Effectiveness in Ra Patients Is Independent of Smoking Status
SP0065 to Taper or Not to Taper Non Biological Dmards in Ra Remission?
Co1 Comparative Effectiveness Analysis of TNF Blockers in Rheumatoid Arthritis (Ra) Patients in a Real-World Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
THU0725-HPR Cost Effectiveness Analysis of Abatacept Compared With TNF Inhibitors in Patients Who Are Positive for Anti-Citrullinated Protein Antibodies Based on Results From an Observational Trial
Ultrasonographic Efficacy of Biologic and Targeted Synthetic DMARDs Therapy in RA From Multicenter RA Ultrasound Prospective Cohort in Japan
Arthritis Care and Research
Rheumatology
SAT0206 Retention of Tocilizumab as Monotherapy Versus TNF Inhibitors With Conventional Synthetic Dmards in Rheumatoid Arthritis Patients With Inadequate Response to TNF Inhibitors: A Study From the Tocerra Collaboration
Expressions of Circadian Clock Genes Represent Disease Activities of RA Patients Treated With Biological DMARDs
Modern Rheumatology
Medicine
Rheumatology